iBB

Polyurea oxide (PURO) biodendrimers are a class of dendrimers that can trigger osteogenic differentiation of human mesenchymal stem cells (hMSCs). The effect of PURO biodendrimers in the differentiation of hMSCs was found by the single addition to a standard growth medium for MSCs differentiation (without differentiation inducers, e.g. dexamethasone, ascorbic acid, and β-glycerophosphate). These results, published in ACS Applied Bio Materials by Rita Pires and Vasco Bonifácio from BSIRG-iBB and with colleague João Conde from NOVA Medical School, constitute the first report of in vitro osteodifferentiation fully regulated by synthetic soft polymers. The outstanding role of dendrimers in nanomedicine, under clinic translation, combined with this feature is envisaged to foster PURO dendrimers as an important strategy in cell therapy and regenerative medicine.